Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients

This study has been terminated.
(Poor recruitment and through put)
Sponsor:
Information provided by:
Valen Labs
ClinicalTrials.gov Identifier:
NCT00329485
First received: May 23, 2006
Last updated: August 1, 2007
Last verified: August 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2007
  Estimated Primary Completion Date: No date given